Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001615774-16-006875
Filing Date
2016-08-18
Accepted
2016-08-18 17:18:19
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3/A s102059_s3a.htm S-3/A 540855
2 EXHIBIT 5.1 s102059_ex5-1.htm EX-5.1 15691
3 EXHIBIT 10.1 s102059_exhibit10-1.htm EX-10.1 167595
4 EXHIBIT 10.2 s102059_exhibit10-2.htm EX-10.2 63514
5 EXHIBIT 23.1 s102059_ex23-1.htm EX-23.1 1933
7 GRAPHIC tlogo.jpg GRAPHIC 4484
8 filename8.htm CORRESP 29435
  Complete submission text file 0001615774-16-006875.txt   826505
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-3/A | Act: 33 | File No.: 333-207600 | Film No.: 161841542
SIC: 8731 Services-Commercial Physical & Biological Research